Assessing pharmacokinetic interactions between the sodium glucose cotransporter 2 inhibitor empagliflozin and hydrochlorothiazide or torasemide in patients with type 2 diabetes mellitus: a randomized, open-label, crossover study (Q38417013)
Jump to navigation
Jump to search
scientific article published on 28 January 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Assessing pharmacokinetic interactions between the sodium glucose cotransporter 2 inhibitor empagliflozin and hydrochlorothiazide or torasemide in patients with type 2 diabetes mellitus: a randomized, open-label, crossover study |
scientific article published on 28 January 2015 |
Statements
1 reference
Assessing pharmacokinetic interactions between the sodium glucose cotransporter 2 inhibitor empagliflozin and hydrochlorothiazide or torasemide in patients with type 2 diabetes mellitus: a randomized, open-label, crossover study (English)
1 reference
Tim Heise
1 reference
Michaela Mattheus
1 reference
Hans J Woerle
1 reference
Uli C Broedl
1 reference
Sreeraj Macha
1 reference
28 January 2015
1 reference
1 reference
Identifiers
1 reference